247 related articles for article (PubMed ID: 19744643)
61. Would patient selection based on both calcitonin blood level and doubling time improve 18F-FDG PET sensitivity in restaging of medullary thyroid cancer?
Aide N; Bardet S
J Nucl Med; 2007 Sep; 48(9):1574; author reply 1574-5. PubMed ID: 17785732
[No Abstract] [Full Text] [Related]
62. Medullary thyroid carcinoma in a patient with Hashimoto's thyroiditis diagnosed by calcitonin washout from a thyroid nodule.
Mousa U; Gursoy A; Ozdemir H; Moray G
Diagn Cytopathol; 2013 Jul; 41(7):644-6. PubMed ID: 22102446
[TBL] [Abstract][Full Text] [Related]
63. Progression of Focal to Diffuse Thyroid Uptake Detected by 18F-FDG PET/CT: Malignant Metastatic Disease or Benign Thyroiditis?
Thuillier P; Crouzeix G; Descourt R; Salaun PY; Abgral R
Clin Nucl Med; 2018 Sep; 43(9):e310-e311. PubMed ID: 29939952
[TBL] [Abstract][Full Text] [Related]
64. Role of PET in medullary thyroid carcinoma.
Rufini V; Treglia G; Perotti G; Leccisotti L; Calcagni ML; Rubello D
Minerva Endocrinol; 2008 Jun; 33(2):67-73. PubMed ID: 18388854
[TBL] [Abstract][Full Text] [Related]
65. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects.
Chen YK; Ding HJ; Chen KT; Chen YL; Liao AC; Shen YY; Su CT; Kao CH
Anticancer Res; 2005; 25(2B):1421-6. PubMed ID: 15865100
[TBL] [Abstract][Full Text] [Related]
66. Detection of thyroid malignancy in a hot nodule by fluorine-18-fluorodeoxyglucose positron emission tomography.
Low SC; Sinha AK; Sundram FX
Singapore Med J; 2005 Jun; 46(6):304-7. PubMed ID: 15902360
[TBL] [Abstract][Full Text] [Related]
67. Simultaneous occurrence of medullary and papillary carcinoma of the thyroid gland identified by fine needle aspiration. A case report.
Merchant FH; Hirschowitz SL; Cohan P; Van Herle AJ; Natarajan S
Acta Cytol; 2002; 46(4):762-6. PubMed ID: 12146049
[TBL] [Abstract][Full Text] [Related]
68. Successful surgical removal of occult metastases of medullary thyroid carcinoma recurrences with the help of immunoscintigraphy and radioimmunoguided surgery.
de Labriolle-Vaylet C; Cattan P; Sarfati E; Wioland M; Billotey C; Brochériou C; Rouvier E; de Roquancourt A; Rostène W; Askienazy S; Barbet J; Milhaud G; Gruaz-Guyon A
Clin Cancer Res; 2000 Feb; 6(2):363-71. PubMed ID: 10690512
[TBL] [Abstract][Full Text] [Related]
69. Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.
Carr LL; Mankoff DA; Goulart BH; Eaton KD; Capell PT; Kell EM; Bauman JE; Martins RG
Clin Cancer Res; 2010 Nov; 16(21):5260-8. PubMed ID: 20847059
[TBL] [Abstract][Full Text] [Related]
70. Mixed medullary-papillary carcinoma of the thyroid with lymph node metastases: report of a case.
Shiroko T; Yokoo N; Okamoto K; Kitakado Y; Azuma H; Fukui T; Tanaka C
Surg Today; 2001; 31(4):317-21. PubMed ID: 11321340
[TBL] [Abstract][Full Text] [Related]
71. 18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literature.
Gotthardt M; Battmann A; Höffken H; Schurrat T; Pollum H; Beuter D; Gratz S; Béhé M; Bauhofer A; Klose KJ; Behr TM
Nucl Med Commun; 2004 May; 25(5):439-43. PubMed ID: 15100501
[TBL] [Abstract][Full Text] [Related]
72. Can injection of pentagastrin stimulate the identification of metastases of medullary thyroid carcinoma by (18)F-FDG PET/CT?
Erdoğan MF; Demir O; Ozkan E; Küçük ON
Hell J Nucl Med; 2012; 15(2):155-6. PubMed ID: 22741153
[No Abstract] [Full Text] [Related]
73. Incidental Detection of Oxyphilic Papillary Thyroid Carcinoma by 18F-Fluorocholine PET/CT.
Lalire P; Zalzali M; Garbar C; Bruna-Muraille C; Morland D
Clin Nucl Med; 2016 Jun; 41(6):512-3. PubMed ID: 26914574
[TBL] [Abstract][Full Text] [Related]
74. Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study.
Musholt TJ; Musholt PB; Dehdashti F; Moley JF
Surgery; 1997 Dec; 122(6):1049-60; discussion 1060-1. PubMed ID: 9426419
[TBL] [Abstract][Full Text] [Related]
75. [High carcinoembryonic antigen level following cancer surgery: another way to detect thyroid medullary carcinoma].
Martinez M; Virally ML; Guillausseau-Scholer C; Vincenot M; Samuel-Lajeunesse J; Mauvais-Jarvis F; Kévorkian JP; Porokhov B; Valleur P; Guillausseau PJ
Rev Med Interne; 2000 Oct; 21(10):897-900. PubMed ID: 11075399
[TBL] [Abstract][Full Text] [Related]
76. (18)F-FDG PET discovered an elusive cervical inflammatory pseudotumor associated with a papillary thyroid cancer.
Modesto J; Gardeazabal I; Santos AM; Galofré JC
Endocrinol Nutr; 2014; 61(6):338-40. PubMed ID: 24721020
[No Abstract] [Full Text] [Related]
77. Review of fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in the follow-up of medullary and anaplastic thyroid carcinomas.
Khan N; Oriuchi N; Higuchi T; Endo K
Cancer Control; 2005 Oct; 12(4):254-60. PubMed ID: 16258498
[TBL] [Abstract][Full Text] [Related]
78. A letter regarding diagnostic accuracy of ultrasound and 18-F-FDG PET or PET/CT for patients with suspected recurrent papillary thyroid carcinoma.
Ahmadzadehfar H; Biermann K; Sabet A; Biersack HJ
Ultrasound Med Biol; 2011 May; 37(5):840; author reply 841. PubMed ID: 21168262
[No Abstract] [Full Text] [Related]
79. Potential role of fluorine-18-deoxyglucose (FDG) positron emission tomography (PET) in the staging of primitive and recurrent medullary thyroid carcinoma.
Gasparoni P; Rubello D; Ferlin G
J Endocrinol Invest; 1997 Oct; 20(9):527-30. PubMed ID: 9413806
[TBL] [Abstract][Full Text] [Related]
80. [Diagnosis of metastasis of malignant melanoma in the thyroid gland with f18-FDG PET scan].
Wolf G; Aigner RM; Schwarz T; Nicoletti R
Hautarzt; 2002 May; 53(5):332-3. PubMed ID: 12063745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
